BioMarin Pharmaceutical Inc. (BMRN)

BioMarin Pharmaceutical Market Cap

BioMarin Pharmaceutical has a market cap or net worth of $11.33 billion as of January 9, 2026. Its market cap has decreased by -9.50% in one year.

• Market Cap: 11.33B
• Enterprise Value: 10.44B
• 1-Year Change: -9.50%
• Ranking: #877
• Category: Large-Cap
• Stock Price: $58.95

Market Cap Chart

Since July 26, 1999, BioMarin Pharmaceutical's market cap has increased from $443.40M to $11.33B, an increase of 2,454.16%. That is a compound annual growth rate of 13.02%.

Market Cap History

Date	Market Cap	% Change
Jan 8, 2026	11.59B	1.55%
Dec 31, 2025	11.42B	-8.86%
Dec 31, 2024	12.53B	-31.03%
Dec 29, 2023	18.16B	-5.57%
Dec 30, 2022	19.23B	18.58%
Dec 31, 2021	16.22B	1.90%
Dec 31, 2020	15.92B	4.81%
Dec 31, 2019	15.19B	0.17%
Dec 31, 2018	15.16B	-3.18%
Dec 29, 2017	15.66B	9.92%
Dec 30, 2016	14.25B	-15.66%
Dec 31, 2015	16.89B	26.72%
Dec 31, 2014	13.33B	33.25%
Dec 31, 2013	10.00B	64.58%
Dec 31, 2012	6.08B	54.81%
Dec 30, 2011	3.93B	42.26%
Dec 31, 2010	2.76B	45.68%
Dec 31, 2009	1.89B	6.63%
Dec 31, 2008	1.78B	-48.15%
Dec 31, 2007	3.43B	128.90%
Dec 29, 2006	1.50B	87.98%
Dec 30, 2005	796.50M	93.28%
Dec 31, 2004	412.10M	-16.92%
Dec 31, 2003	496.00M	31.08%
Dec 31, 2002	378.40M	-36.33%

View and export this data all the way back to 1999. Sign Up Today.

Related Stocks

Company	Market Cap
Eli Lilly and Company	992.16B
Johnson & Johnson	499.90B
AbbVie	412.54B
UnitedHealth Group	309.53B
AstraZeneca	297.23B
Novartis AG	273.49B
Merck & Co.	269.55B
Novo Nordisk	254.60B